- Country: USA
- Summary: Subject Matter Expert Consultant for Medicinal Chemistry.
- UST Ref No: 124211035
- Deadline: 22 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N95025Q00055
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The NIH is seeking executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in Medicinal Chemistry to provide technical guidance to the following programs:
Medicinal Chemistry consulting to procure consultant services to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development programs in the area of Medicinal Chemistry. Other NIH neuroscience-focused drug discovery and development programs.Please see the attachments for more details. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSubject Matter Expert Consultant for Medicinal Chemistry. - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Subject Matter Expert Consultant for Medicinal Chemistry.. This tender is published on USARFP under UST Ref No: 124211035 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-22.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
